AE standard errors of mean. Data were analyzed using 1-way analysis of variance with post hoc Dunnett's test. RESULTS: Prothrombin production and localization were confirmed by Western blot and immunostainings in all primary fetal membrane cells and tissue explants. Immunofluorescence observations revealed a perinuclear localization of prothrombin in amnion epithelial cells. Localization of prothrombin in chorion and decidua cells was perinuclear and cytoplasmic. Prothrombin messenger RNA and protein expression in fetal membranes were increased significantly by Ureaplasma parvum, but not lipopolysaccharide, treatments in a dose-dependent manner. Specifically, Ureaplasma parvum at a dose of 1Â10 7 colony-forming units/mL significantly increased both prothrombin messenger RNA (fold changes in amnion: 4.1AE1.9; chorion: 5.7AE4.2; decidua: 10.0AE5.4; fetal membrane: 9.2AE3.0) and protein expression (fold changes in amnion: 138.0AE44.0; chorion: 139.6AE15.1; decidua: 56.9AE29.1; fetal membrane: 133.1AE40.0) compared with untreated control subjects. Ureaplasma parvum at a dose of 1Â10 6 colony-forming units/mL significantly upregulated prothrombin protein expression in chorion cells (fold change: 54.9AE5.3) and prothrombin messenger RNA expression in decidua cells (fold change: 4.4AE1.9). CONCLUSION: Our results demonstrate that prothrombin can be produced directly by fetal membrane amnion, chorion, and decidua cells. Further, prothrombin production can be stimulated by Ureaplasma parvum exposure in fetal membranes. These findings represent a potential novel underlying mechanism of Ureaplasma parvumeinduced rupture of fetal membranes. P reterm birth (PTB) remains a major public health problem and complicates approximately 10% of deliveries in the United States. 1 Preterm premature rupture of membranes (PPROM) accounts for approximately one-third of all PTB. 2 
Prevention
of pregnancy complications through enhanced understanding and appropriate intervention is of critical importance to improve both maternal and neonatal outcomes. The causes of PPROM are multifactorial and include pathologic anatomic remodeling, 3, 4 altered membrane morphology, [5] [6] [7] [8] [9] [10] complications from invasive procedures, 11 inflammation, [12] [13] [14] and genetic factors. [15] [16] [17] Although the mechanisms of PPROM are not well-understood, infection in the fetal membranes has been implicated as an early event in the pathogenesis of PPROM and/or preterm labor. [18] [19] [20] [21] [22] [23] [24] [25] Histologic chorioamnionitis complicates almost one-half of all PPROM cases. 26 The propagation of bacteria is an important contributing factor not only in PPROM but also in adverse neonatal and maternal complications after PPROM.
Ureaplasma spp are among the organisms frequently implicated in prematurity-linked conditions and chorioamnionitis. [27] [28] [29] [30] [31] [32] [33] [34] The 2 species of Ureaplasma that are known to colonize humans are U urealyticum and U parvum. Of these, U parvum is the most common species to be isolated from the genital tract of men and women. 29, 35, 36 Increasing evidence suggests that U parvum is an significant pathogen in pregnancy and is associated with 37 Specifically, U parvum is the most frequently isolated pathogen in the amniotic fluid of women who deliver preterm, 22, 31, 32, 35 and its colonization in neonates is related inversely to gestational age at delivery. 28, 38 A recent study of the human microbiota during pregnancy indicated that elevated vaginal Ureaplasma, when combined with poor vaginal colony state, was associated with PTB. 39 The presence of U parvum, but not U urealyticum, in vaginal fluid during pregnancy was associated significantly with higher risk of spontaneous PTB in an Australian cohort of pregnant women. 40 Another study demonstrated that human placenta infection with Ureaplasma is associated with histologic chorioamnionitis and adverse outcomes in moderate-and late-preterm infants. 41 The strongest evidence to link U parvum to preterm labor is from experiments in animal models. Intraamniotic inoculation of U parvum resulted in chorioamnionitis in rhesus macaques 42, 43 and sheep 40 and also promoted preterm delivery in the former. 42 However, to date, the pathogenicity of U parvum in PTB is understood poorly. 44 Using our in vitro fetal membrane infection model, we have demonstrated that U parvum adheres to fetal membrane cells and induces inflammation. 45, 46 Using the same model, we harvested the condition media to identify the proteins stimulated by U parvum infection using a proteomics-based approach. Prothrombin was detected in U parvumetreated condition media, but not control condition media. This preliminary finding indicated that U parvum has the potential to induce prothrombin production in fetal membrane cells. We postulate that infectioninduced prothrombin production (and subsequent conversion to thrombin) might be a novel mechanism of U parvum pathogenicity in PTB. [47] [48] [49] [50] [51] [52] [53] [54] Thrombin generation has been associated with fetal membrane weakening and PPROM, 50, 54 and treatment of amnion explants with thrombin results in increased levels of matrix metallopeptidase 9 and mechanical weakening. 55 However, thrombin generation in fetal membranes and the source of thrombin in amniotic fluid is not welldescribed. 47, 56 Decidual hemorrhage associated with either intrauterine infection 57 or bleeding in pregnancy 58 is thought to be a primary source of thrombin. The ability of fetal membrane cells (amnion, chorion, and decidua) to produce prothrombin and respond to infection through regulating prothrombin production is not established.
In this study, we hypothesize that U parvum exposure stimulates prothrombin production in fetal membrane amnion, chorion, and decidua cells. Our objectives were 2-fold: (1) to confirm the prothrombin localization in fetal membrane cells with immunostaining in ex vivo fetal membrane tissues and primary cultured fetal membrane cells and (2) to quantify prothrombin expression with Western blot analysis and polymerase chain reaction (PCR) in fetal membrane tissues and cells with/without U parvum exposure. In addition, each pathogen may elicit a unique response through specific signaling mechanisms. In this study, Gram-negative bacterial lipopolysaccharide was used as a comparison. Gram-negative bacteria also are associated frequently with intraamniotic infections, and lipopolysaccharide is often used to induce PTB in animal models.
Materials and Methods
This study used human fetal membrane tissues that were collected after planned, uncomplicated cesarean delivery at term without rupture of membranes or labor and a genital isolate U parvum strain, as described previously. 45 
Fetal membrane tissue explant and primary cell cultures
For tissue explant culture, fetal membranes were collected after planned, uncomplicated cesarean delivery at term (39 weeks of gestation) without rupture of membranes or labor. All subjects had no previous PTB and were not on progesterone therapy. All subjects had no pregnancy or medical complications. Membranes were washed in warm media, and blood clots were removed. Fullthickness fetal membrane tissue was cut into 1Â1ecm pieces and cultured in DMEM/F12 media supplemented with 10% fetal bovine serum in 6-well plates. The fetal membrane fragments were collected away from the area near the disk or the rupture site.
For primary cell culture, fetal membranes were cut into 2Â2einch pieces. The reflected amnion layer was removed manually. Amnion epithelial cells were harvested with a modification of a technique that had been described previously. 45, 59 Briefly, the amnion tissue was minced and digested in DMEM/F12 that contained 0.2% trypsin (Sigma Chemical Company, St. Louis, MO) at AJOG at a Glance Why was this study conducted? Epidemiologic and experimental studies have demonstrated that thrombin causes fetal membrane weakening and preterm premature rupture of membranes. However, the sources of thrombin in the fetal membranes and amniotic fluid of preterm premature rupture of membranes patients were previously unknown. This study aimed to investigate whether thrombin production by fetal membrane cells can be induced by Ureaplasma parvum exposure.
Key Findings
The key findings are 2-fold: (1) prothrombin can be produced directly by fetal membrane amnion, chorion, and decidua cells, and (2) prothrombin production can be stimulated by U parvum exposure in fetal membranes.
What does this add to what is known?
We discovered a potential novel mechanism by which U parvum infection induces alteration of fetal membranes.
Original Research OBSTETRICS ajog.org 37 C for 30 minutes with periodic agitation. The mixture was then filtered with the use of a tissue strainer to separate the dispersed amnion epithelial cells from the tissue fragments. This process was repeated 3 times, and the dispersed epithelial cells were combined and counted. The yield was 8e12 million amnion epithelial cells/g of amnion tissue; viability was 90% (assessed by trypan blue dye exclusion).
Separation of the decidua and chorion involved blunt dissection with forceps and scalpel. Separated chorion and decidua layers were minced and digested in DMEM/F-12 that contained 0.125% trypsin and 0.2% collagenase (Sigma Chemical Company) at 37 C for 30e90 minutes with periodic agitation. Cells were filtered through 70-mm nylon cell filters (Falcon Cell Strainer; Fisher Scientific, Waltham, MA). A cell-separation gradient was prepared to purify the cells as described previously. 60 Cells were plated in the same culture conditions as amnion cells for 48 hours. Purity of primary cells was confirmed with the use of immunofluorescence staining for cytokeratin and vimentin to distinguish amnion/chorion from decidua cells.
All cell types or tissue explants were confirmed to be free of Mycoplasma and Ureaplasma contamination by a chemiluminescent-labelled singlestranded DNA probe hybridization method (MTC-NI kit; Merck-Millipore Corporation, Burlington, MA).
Tissue explants (0.5Â0.5 cm) and primary cells (2Â10 6 cells/well in 6-well plates) were treated with and without live U parvum (1Â10 
Immunohistochemistry staining
To determine basal prothrombin protein localization in fetal membranes, freshly harvested, full-thickness fetal membranes without U parvum infection were fixed in 10% formalin for immunohistochemistry. Paraffin sections were dewaxed and rehydrated. After heatinduced antigen retrieval, the sections were stained with the anti-mouse HRP-DAB Cell & Tissue Staining Kit according to the manufacturer's instruction (R&D Systems, Minneapolis, MN). Mouse anti-human thrombin antibody (Abcam Inc, Cambridge, UK) was used at a 1:500 dilution in PBS with 1% BSA and 5% goat serum. Placenta tissue was used as positive control. For each batch of staining, 1 slide was incubated with normal mouse immunoglobulin G (Abcam Inc) instead of the primary antibody as a negative control. Images were taken using a Zeiss Axio Observer (Â20; Zeiss, Oberkochen, Germany). Three rounds of immunohistochemistry staining were performed using fetal membrane tissues collected from three subjects.
Immunofluorescence staining
To determine the localization of thrombin/prothrombin protein in fetal membrane cells, primary cell cultures without U parvum infection were fixed with cold methanol at e20 C for 10 minutes. The cells were permeabilized and blocked with 1% BSA, 5% normal goat serum, and 0.1% Tween-20 in phosphate-buffered saline solution for 1 hour. After being blocked, the slides were incubated with primary antibodies overnight at 4 C. Primary mouse anticytokeratin and anti-vimentin monoclonal antibodies (Dako Corp, Santa Clara, CA) were used at 1:200 and rabbit anti-thrombin polyclonal antibody (Abcam Inc) was used at 1:100. Antimouse and rabbit immunoglobulin G antibodies were used as negative controls (R&D Systems). Goat anti-mouse secondary antibody Alexa Fluor 488 conjugate and goat anti-rabbit secondary antibody Alexa Fluor 594 (Life Technologies, Carlsbad, CA) were used at 1:500. Slides were mounted with the use of mounting medium for fluorescence with DAPI (Vector Laboratories, Burlingame, CA). Three rounds of immunofluorescence staining were performed with fetal membrane tissues that were collected from 3 subjects. 
Real-time quantitative reverse transcription PCR

ELISA
The conditioned media were analyzed for prothrombin/thrombin protein concentrations by Human Thrombin ELISA Kit (Factor II; 61 Abcam). Samples without dilution were run in duplicate with serial dilutions of recombinant human thrombin as standards. The sensitivity of this Kit is approximately 0.3 ng/mL. The intra-and interassay coefficients of variation are 4.7% and 7.2%, respectively. The absorbance was measured at an optical density of 450 nm, with correction at an optical density of 540 nm. Eight replicates were performed with the fetal membrane tissues or primary cells that had been collected from 8 subjects.
Data analysis
Experiments that were performed with tissue explant or primary cell culture from 1 subject were counted as 1 repeat. All experiments were repeated >5 times. Data are presented as means AE SEMs. The 1-way analysis of variance with the post-hoc Dunnett's test was used for multiple comparisons. A probability value of <.05 was considered statistically significant. Statistical analyses were performed with GraphPad Prism (version 6.0; GraphPad Software, Inc, La Jolla, CA).
Results
Prothrombin/thrombin protein detected in fetal membrane cells
To demonstrate the localization of thrombin/prothrombin in the fetal membrane cells, we performed immunohistochemistry in full-thickness fetal membrane tissues and immunofluorescence staining in primary cultured fetal membrane cells. Positive prothrombin/thrombin staining was observed consistently in the amnion and chorion layers of fetal membranes ( Figure 1 ). Prothrombin/thrombin staining in the decidua layer of fetal membranes was inconsistent, with negative staining observed in the fetal membranes of some subjects and positive staining observed in others. Even within the same sample, there were inconsistencies among stained cells in the decidual layer. Additionally, with the use of the same staining conditions (same batch), the intensity of prothrombin/ thrombin staining in all 3 layers of fetal membranes varied between subjects ( Figure 1 , A: weak staining in subject 1 vs strong staining in subject 2).
Intracellular staining indicated the presence of prothrombin, but extracellular prothrombin/thrombin staining was also observed. Using immunofluorescence, we further verified prothrombin/thrombin localization in primary cultured fetal membrane cells (Figure 2) . In amnion cells, prothrombin/thrombin staining was predominately perinuclear, whereas in chorion and decidua cells, the staining was diffuse in the cytoplasm (Figure 2 ).
Prothrombin mRNA and protein expression was up-regulated after U parvum exposure in fetal membrane explants and cells
Although not statistically significant at all doses, both prothrombin transcripts and protein expression were 
Prothrombin/thrombin staining in fetal membranes
A, Prothrombin/thrombin protein was present in the amnion, chorion, and decidua layers of the fetal membranes. Prothrombin/thrombin immunostaining intensity in subject 2 was much higher than in subject 1, which represented the variable expression of this protein among term fetal membranes. Negative control fetal membranes were stained negative. B, Negative control and positive control of prothrombin/thrombin immunostaining in placenta tissues. Thrombin/prothrombin staining in placentas was in syncytiotrophoblasts and fetal vessels. Original Research OBSTETRICS ajog.org up-regulated after U parvum exposure in a dose-dependent manner. The lack of statistical significance for some of the lower doses may result from individual subject variability and the low virulence of U parvum at low dose in fetal membranes.
U parvum, at the highest dose (1Â10 7 cfu/mL), consistently and significantly increased prothrombin/thrombin mRNA expression in tissue explants (P<.01) and primary fetal membrane cells (P<.05; Figure 3 ; n¼6). Treatments with lipopolysaccharide (100 ng/mL or 1000 ng/mL) and lower doses (1Â10 5 or 1Â10 6 cfu/mL) of U parvum did not significantly change the prothrombin/ thrombin mRNA expression in tissue explants and primary fetal membrane cells, with the exception of a dose of U parvum 1Â10 6 cfu/mL in decidua cells (P<.05). The results are summarized in the Table. A band at approximately 75 kDa was detected in Western blots for all fetal membrane samples. A single band at approximately 72 kDa was identified for purified plasma prothrombin (Figure 4) , which further demonstrated the specificity of the antibody. The slight molecular weight difference might be due to the modifications in prothrombin before secretion, such as signal-peptide cleavage, 62 complex glycosylation, 63 and disulphide-bridge formation. 64 The densitometry analysis of Western blots (n¼5) is consistent with the quantitative reverse transcriptaseePCR findings that demonstrated that U parvum up-regulated prothrombin protein expression in a dose-dependent manner. Chorion cells were more susceptible than amnion or decidua cells to U parvum exposureeinduced prothrombin protein expression, as demonstrated by significant induction at both high (1Â10 7 cfu/mL; P<.001) and medium (1Â10 6 cfu/mL; P<.001) U parvum doses. In amnion and decidua cells and tissue explants, prothrombin protein expression was significantly induced by U parvum at 1Â10 7 cfu/mL (P<.05), but not at lower doses.
The prothrombin/thrombin protein in conditioning media not significantly induced by U parvum exposure Prothrombin/thrombin was detectable in culture supernatants that were collected from fetal membrane cells and tissue explant cultures at approximately 100 and 2000 pg/mL, respectively ( Figure 5 ). In amnion and chorion cell culture supernatants, U parvum exposure at 1Â10 7 cfu/mL resulted in increased prothrombin/thrombin concentration, but results were not statistically significant (n¼8).
Comment
Principal findings of the study
In this study, we characterized prothrombin expression in cells of the fetal membranes and demonstrated that U parvum exposure induced prothrombin production by fetal membrane cells. Interestingly, we were not able to demonstrate that lipopolysaccharide induced prothrombin production either in fetal membranes or in cells derived from fetal membranes.
Clinical and research implications
These findings suggest (1) a connection between microorganisms and thrombin production in cells of the fetal membranes and (2) a possible pathogenicity of Ureaplasma that is not understood completely. This novel discovery significantly contributes to our understanding of the pathogenicity of U parvum and U parvum infectioneinduced PTB and PPROM. Although numerous clinical observational studies regarding Ureaplasma spp infection during pregnancy have been conducted in the past 3 decades, its clinical significance is still debated. 65, 66 It is a commonly held belief that Ureaplasma spp are not pathogenic because they are common commensal organisms in the female genital tract and often detected in gestational tissues. Ureaplasma spp are considered to be low-virulence bacteria. In fact, studies Prothrombin/thrombin expression in primarily cultured fetal membrane cells
Cytokeratin and vimentin stained in green; prothrombin/thrombin stained in red, and DAPI (Vector Laboratories, Burlingame, CA) stained in blue. 
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that have evaluated the impact on pregnancy of treatment of Ureaplasma and Mycoplasma spps have had mixed results. 67, 68 Our findings support a pathogenic mechanism for Ureaplasma by which it stimulates prothrombin production in gestational tissues. The previously reported Ureaplasma virulence factors include adhesion molecules, 69 immunoglobulin A protease, 70 urease, 71 phospholipases A and C, 72 and the production of hydrogen peroxide. 73 However, examination of the genome of multiple serovars of Ureaplasma failed to reveal genes that encode these enzymes. 74 The multiple-banded antigen (MBA) of Ureaplasma is the predominant antigen recognized during the infection process and may be involved in the stimulation of host inflammatory response. 75 Our findings indicate that there are potential undiscovered Ureaplasma virulence factors that regulate host coagulation and hemostasis. Coagulation modifications induced by Ureaplasma in fetal membranes indicate that Ureaplasma has the potential to act as an opportunistic pathogen during pregnancy. Our discovery sheds new light on the long-established, yet poorly understood, link between infection/inflammation and PTB: U parvumeinduced thrombin production. Thrombin acts as a serine protease that converts soluble fibrinogen into insoluble strands of fibrin and also catalyzes many other coagulation-related reactions. Beyond its key role in the dynamic process of thrombus formation, thrombin has pronounced proinflammatory properties that act via its specific cell membrane proteaseactivated receptors (PARs). [76] [77] [78] [79] [80] [81] PARs, which control important physiologic and disease-relevant tissue-specific processes, are an emerging therapeutic target for major diseases such as burns and gastric ulcers. 82 The mechanisms of actions of PARs are understood poorly in gestational tissues. Fetal membrane cells express PAR-1; 83,84 thrombin induces inflammation and weakens fetal membranes, 50, 54, 55, 83, 84 and alternative mechanisms of thrombin action have also been demonstrated. For example, 1 study reported that thrombin weakens the amnion extracellular matrix directly rather than through PARs. 84 Proteinand/or peptide-based therapies targeted to limit thrombin enzyme activities and ultimately reduce the risk of PPROM should be explored.
After bacterial infection, the resultant inflammatory reaction activates a coagulation cascade that results in the formation of fibrin, which effectively walls off the infection. 85 , 86 Mackman 87 postulated that coagulation is an important component of the inflammatory response and necessary to eliminate the infection. The prevailing view is that coagulation-factor production is restricted to 3 compartments: the liver, where most coagulation factor production takes place; the endothelium, which is characterized, for example, by high levels of von Willebrand factor; and the platelets, which, despite being devoid of nuclei, are capable of substantial coagulation factor production. 88 However, there is evidence to refute this simplistic model of coagulation-factor synthesis. For instance, in the lung, alveolar macrophages express factor VIIa 89 ; epithelial cells express tissue factor, 90 factor VIIa, 91 and factor Xa 92 ; and fibroblasts express tissue factor pathway inhibitor. 93 Our current study also challenges the standard paradigm of coagulation factor production by confirming prothrombin biosynthesis in human fetal membrane cells that include amnion epithelial cells, chorion trophoblasts, and decidua stroma cells. Among these cells, there are differences in the distribution of prothrombin and the susceptibility to prothrombin stimulation after U parvum exposure. Our findings suggest a Original Research OBSTETRICS ajog.org different functional relevance of prothrombin in these cell types. Based on the size of the single band detected by Western blot, the stimulated prothrombin was not activated within the intracellular and pericellular spaces of these cells. Although prothrombin mRNA and protein were up-regulated consistently after U parvum exposure, the prothrombin levels in culture supernatants were extremely variable, ranging from below detection to a 5-fold increase in U parvumetreated groups. The individual patient variability is not explained easily, but this may be a result of the complexity of prothrombin secretion and the instability of prothrombin in media. Additionally, because it is impossible to avoid blood contamination in the culture media of full-thickness fetal membranes, this could explain, in part, the variable results in tissue explants. Our objective in this current study was to demonstrate the ability of gestational tissues to synthesize prothrombin and respond to U parvum exposure. Future studies to understand the individual patient variability and downstream effects of fetal membrane prothrombin biosynthesis and secretion induced by U parvum are warranted.
Strengths and limitations
A standard bacterial inoculum is critically important for in vivo and in vitro studies. We previously demonstrated that the quantity of bacteria present in the fetal membranes is correlated with chorion thinning, which suggests that bacterial presence may incrementally evoke a host response that leads to chorion cell death and tissue degradation. 94 There is now evidence that the dose and variation of the MBA of U parvum might affect the severity of chorioamnionitis in pregnant sheep. 95 Therefore, we optimized the doses of U parvum and treatment duration to avoid cell death, as observed in our previous studies. 45, 96 The optimized dose range was chosen because (1) the consistent and effective induction of interleukin 8, cyclooxygenase 2, prostaglandin E2, and matrix metallopeptidase 9 in these cultures was observed, (2) cell death was not observed for the treatment duration, (3) the multiplicity of infection of 5 (for example, 10 7 cfu U parvum to 2Â10 6 fetal membrane cells) was within the range of positive adherence to fetal membrane cells; and (4) the multiplicity of infection of U parvum in this study is consistent with other studies in human amniotic epithelial cells. 97 In this study, 10 8 cfu U parvum infected 10 7 amniotic epithelial cells with a multiplicity of infection of 10. 97 Based on methods previously published, we have established standardized experimental procedures to ensure that the experiments can be compared directly. 45 Overgrowth of U parvum in cell culture is not a concern because of their unique growth conditions: high concentrations of urea, a variety of amino acid supplementation, and acidic conditions of the culture media.
Live U parvum was used in this study for several reasons. The ability of U parvum to have pathogenicity is dependent on its adherence to human cells. The proposed major virulence factor of U parvum, MBA, is a surface protein that is altered easily by heat unlike endotoxin, the major virulence factor of Escherichia coli. Heat inactivation can affect the surface of U parvum and therefore attenuate adherence and damage the protein structure of MBA, both of which will result in variations in host-microbe interactions. As expected, our preliminary data suggest that heat inactivation attenuated the ability of U parvum ability to adhere to human cells. A Specific limitations of our study include the use of lipopolysaccharide instead of live E coli to compare with U parvumeinduced thrombin generation. Lipopolysaccharide was selected because of the rapid overgrowth of live E coli in in vitro culture models, which results in significant cell death and limits the interpretation of findings. Lipopolysaccharide, also known as lipoglycans and endotoxins, are large molecules that consist of a lipid and a polysaccharide composed of O-antigen, outer core, and inner core joined by a covalent bond; they are found in the outer membrane of Gram-negative bacteria and elicit strong immune responses and coagulopathy that includes thrombin generation in animals [99] [100] [101] [102] [103] and humans.
100,101
Although we cannot conclude that E coli does not stimulate prothrombin production in fetal membranes, we extrapolated this based on our finding that lipopolysaccharide treatment failed to induce prothrombin production. Lipopolysaccharide, however, has been shown to stimulate the production of cytokines (such as interleukin-1 and tumor necrosis factor), which may be associated with coagulation. The exact relationship between cytokines and coagulation in fetal membranes is understood poorly. The other limitation of this study is that we did not demonstrate a direct link between prothrombin production and fetal membrane rupture. Because of the complexity of the activation of C, control; cfu, colony-forming units; FM, fetal membrane; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; LPS, lipopolysaccharide; UPA, Ureaplasma parvum (U parvum). Original Research OBSTETRICS ajog.org prothrombin, it is difficult to replicate prothrombin activation in vitro. Many coagulation factors that are necessary for the activation of prothrombin are not present in the cell culture system. Future in vivo studies are warranted.
Conclusion
Our findings demonstrate a potential pathway to PPROM and PTB: U parvum exposure-induced prothrombin production in fetal membrane cells. Ureaplasma spp is understudied, yet recognized, as an important pathogen during pregnancy and in the preterm neonate. Our findings contribute to the field of microbiology and maternal fetal medicine by identifying a novel molecular event that results from the interactions of U parvum and cells of the fetal membranes. Most importantly, the understanding of coagulation regulation as 1 of the U parvum virulence factors in fetal membranes likely will yield novel therapeutic interventions to limit the onset and progression of PTB and PPROM.
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